Sansure Biotech Inc.
SSE:688289.SS
19.92 (CNY) • At close June 11, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 475.488 | 464.014 | 315.623 | 323.549 | 388.589 | 371.657 | 204.848 | 232.522 | 195.174 | 2,382.123 | 1,378.295 | 1,250.19 | 1,439.747 | 1,247.344 | 1,238.872 | 865.489 | 1,162.835 | 1,157.693 | 1,505.26 | 1,700.428 | 399.583 | 122.031 | 76.61 | 84.917 | 81.831 |
| Cost of Revenue
| 110.726 | 464.014 | 69.319 | 119.004 | 73.904 | 116.61 | 55.534 | 78.758 | 63.494 | 1,001.704 | 575.934 | 540.709 | 537.021 | 453.153 | 326.104 | 195.336 | 304.453 | 327.923 | 287.108 | 279.346 | 75.576 | 40.775 | 21.352 | 30.257 | 34.926 |
| Gross Profit
| 364.762 | 0 | 246.304 | 204.545 | 314.684 | 255.047 | 149.314 | 153.764 | 131.68 | 1,380.42 | 802.362 | 709.481 | 902.726 | 794.191 | 912.768 | 670.153 | 858.382 | 829.77 | 1,218.152 | 1,421.082 | 324.007 | 81.256 | 55.258 | 54.661 | 46.904 |
| Gross Profit Ratio
| 0.767 | 0 | 0.78 | 0.632 | 0.81 | 0.686 | 0.729 | 0.661 | 0.675 | 0.579 | 0.582 | 0.567 | 0.627 | 0.637 | 0.737 | 0.774 | 0.738 | 0.717 | 0.809 | 0.836 | 0.811 | 0.666 | 0.721 | 0.644 | 0.573 |
| Reseach & Development Expenses
| 59.028 | 0 | 72.299 | 52.651 | 55.402 | 48.98 | 46.972 | 44.176 | 46.346 | 151.688 | 79.036 | 57.265 | 43.847 | 96.261 | 38.821 | 30.236 | 22.186 | 19.784 | 33.481 | 19.46 | 10.046 | 13.653 | 7.222 | 9.513 | 8.567 |
| General & Administrative Expenses
| 58.46 | 0 | 144.717 | -5.495 | 61.961 | -54.677 | 95.64 | 42.423 | 33.351 | -8.285 | 85.027 | -0.742 | 26.631 | -24.987 | 52.578 | -4.123 | 19.101 | -31.684 | 36.006 | 4.523 | 4.626 | -14.081 | 10.411 | 11.994 | 3.56 |
| Selling & Marketing Expenses
| 148.903 | 0 | 209.678 | 103.836 | 119.731 | 127.232 | 76.801 | 89.055 | 65.333 | 402.311 | 135.34 | 100.907 | 93.67 | 108.042 | 122.565 | 55.16 | 106.56 | 96.65 | 214.731 | 140.904 | 67.52 | 35.858 | 29.493 | 28.592 | 29.15 |
| SG&A
| 207.363 | 817.602 | 354.395 | 137.808 | 179.977 | 190.739 | 172.441 | 131.477 | 98.684 | 394.026 | 220.367 | 100.165 | 120.301 | 83.056 | 175.144 | 51.037 | 125.661 | 64.966 | 250.737 | 145.427 | 72.146 | 21.777 | 39.903 | 40.586 | 32.711 |
| Other Expenses
| -2.723 | -408.801 | -214.623 | 5.453 | 4.399 | 6.616 | -10.876 | -1.916 | -62.288 | 107.045 | -36.142 | 42.592 | -18.039 | 5.606 | -9.893 | -0.487 | -0.807 | -6.638 | -1.818 | -4.919 | -2.496 | -0.747 | -0.714 | 0.024 | -0.619 |
| Operating Expenses
| 263.669 | 408.801 | 212.071 | 185.006 | 230.98 | 233.103 | 168.457 | 175.714 | 82.742 | 652.759 | 263.261 | 200.022 | 146.109 | 233.972 | 188.383 | 108.606 | 135.939 | 131.626 | 276.783 | 183.202 | 89.265 | 54.204 | 44.616 | 44.086 | 45.756 |
| Operating Income
| 101.093 | 55.213 | 34.233 | 19.539 | 83.704 | 21.944 | 254.953 | 39.525 | 71.853 | 448.259 | 559.04 | 554.482 | 778.029 | 553.274 | 748.216 | 587.304 | 732.992 | 711.156 | 920.054 | 1,226.025 | 228.796 | 24.017 | 11.24 | 12.113 | 0.147 |
| Operating Income Ratio
| 0.213 | 0.119 | 0.108 | 0.06 | 0.215 | 0.059 | 1.245 | 0.17 | 0.368 | 0.188 | 0.406 | 0.444 | 0.54 | 0.444 | 0.604 | 0.679 | 0.63 | 0.614 | 0.611 | 0.721 | 0.573 | 0.197 | 0.147 | 0.143 | 0.002 |
| Total Other Income Expenses Net
| -1.946 | -9.132 | -2.325 | -1.626 | -4.488 | -2.777 | -10.876 | -1.916 | -1.416 | -3.489 | 8.211 | -9.786 | -10.746 | 5.606 | -9.893 | -0.487 | -0.807 | -6.638 | -1.818 | -4.919 | -2.496 | -0.747 | -0.714 | 0.024 | -0.619 |
| Income Before Tax
| 99.148 | 46.081 | 31.908 | 79.392 | 109.243 | 56.85 | 244.077 | 37.609 | 70.437 | 444.769 | 559.174 | 544.696 | 767.283 | 558.88 | 738.323 | 586.818 | 732.185 | 704.518 | 918.236 | 1,221.106 | 226.301 | 23.27 | 10.526 | 12.137 | -0.472 |
| Income Before Tax Ratio
| 0.209 | 0.099 | 0.101 | 0.245 | 0.281 | 0.153 | 1.192 | 0.162 | 0.361 | 0.187 | 0.406 | 0.436 | 0.533 | 0.448 | 0.596 | 0.678 | 0.63 | 0.609 | 0.61 | 0.718 | 0.566 | 0.191 | 0.137 | 0.143 | -0.006 |
| Income Tax Expense
| 18.514 | -49.868 | 4.482 | 13.724 | 18.922 | 8.673 | 36.513 | 6.677 | 10.448 | 106.394 | 85.757 | 71.63 | 115.434 | 73.493 | 102.077 | 88.031 | 110.08 | 100.737 | 137.209 | 182.393 | 33.225 | 2.424 | 0.223 | 3.266 | 0.068 |
| Net Income
| 91.735 | 95.95 | 38.721 | 75.681 | 81.025 | 63.998 | 208.047 | 31.663 | 60.013 | 338.433 | 473.437 | 473.068 | 651.863 | 485.559 | 636.246 | 498.787 | 622.105 | 603.782 | 781.027 | 1,038.713 | 193.075 | 20.845 | 10.303 | 8.871 | -0.541 |
| Net Income Ratio
| 0.193 | 0.207 | 0.123 | 0.234 | 0.209 | 0.172 | 1.016 | 0.136 | 0.307 | 0.142 | 0.343 | 0.378 | 0.453 | 0.389 | 0.514 | 0.576 | 0.535 | 0.522 | 0.519 | 0.611 | 0.483 | 0.171 | 0.134 | 0.104 | -0.007 |
| EPS
| 0.16 | 0.099 | 0.068 | 0.13 | 0.14 | 0.11 | 0.36 | 0.055 | 0.1 | 0.58 | 1.2 | 1.2 | 1.12 | 0.82 | 1.6 | 1.25 | 1.05 | 1.62 | 1.41 | 2.89 | 0.36 | 0.061 | 0.02 | 0.025 | -0.001 |
| EPS Diluted
| 0.16 | 0 | 0.068 | 0.13 | 0.14 | 0.11 | 0.36 | 0.055 | 0.1 | 0.58 | 1.2 | 1.2 | 1.11 | 0.82 | 1.6 | 1.25 | 1.05 | 1.62 | 1.41 | 2.89 | 0.36 | 0.061 | 0.02 | 0.025 | -0.001 |
| EBITDA
| 105.248 | 55.213 | 37.383 | 126.311 | 97.72 | 93.95 | 291.42 | 75.958 | 110.564 | 478.644 | 595.283 | 571.138 | 790.37 | 579.642 | 755.173 | 599.645 | 745.477 | 704.518 | 918.291 | 1,229.211 | 231.441 | 23.271 | 15.67 | 17.306 | 3.658 |
| EBITDA Ratio
| 0.221 | 0.119 | 0.118 | 0.39 | 0.251 | 0.253 | 1.423 | 0.327 | 0.566 | 0.201 | 0.432 | 0.457 | 0.549 | 0.465 | 0.61 | 0.693 | 0.641 | 0.609 | 0.61 | 0.723 | 0.579 | 0.191 | 0.205 | 0.204 | 0.045 |